Opus Genetics Earns Fast Company Innovation Recognition for Gene Therapy Pipeline
Clinical-stage biotech Opus Genetics named to Fast Company's 2026 most innovative companies list for gene therapy work in inherited retinal diseases.
IRDgene therapybiopharmaceutical